For research use only. Not for therapeutic Use.
2-Methyl-Celecoxib (CAT: C000507) emerges as an analog of the renowned anti-inflammatory drug Celecoxib. This compound is of interest due to its structural similarity to Celecoxib, which is recognized for its role as a selective inhibitor of cyclooxygenase-2 (COX-2), an enzyme involved in inflammation. The introduction of a methyl group in 2-Methyl-Celecoxib could potentially modulate its pharmacological properties, affecting its binding affinity and interactions. Further research is needed to elucidate the compound’s potential impact on COX-2 inhibition, anti-inflammatory effects, and its potential as a therapeutic agent.
Catalog Number | C000507 |
CAS Number | 170570-09-9 |
Synonyms | 4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; |
Molecular Formula | C₁₈H₁₆F₃N₃O₂S |
Purity | ≥95% |
Solubility | Chloroform (Slightly), Methanol (Slightly) |
Appearance | Off-White to Pale Beige Solid |
Storage | -20°C, Inert atmosphere |
Reference | Simon, L.S., et al.: Arthritis Rheum., 41, 1591 (1998), Silverstein, F.E., et al.: J. Am. Med. Assoc., 284, 1247 (2000), Steinbach, G., et al.: N. Engl. J. Med., 342, 1946 (2000), |